In situ Formation of Polymer Microparticles in Bacterial Nanocellulose Using Alternative and Sustainable Solvents to Incorporate Lipophilic Drugs

Bacterial nanocellulose has been widely investigated in drug delivery, but the incorporation of lipophilic drugs and controlling release kinetics still remain a challenge. The inclusion of polymer particles to encapsulate drugs could address both problems but is reported sparely. In the present stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Tom Bellmann (Author), Jana Thamm (Author), Uwe Beekmann (Author), Dana Kralisch (Author), Dagmar Fischer (Author)
Format: Book
Published: MDPI AG, 2023-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d94e7b4cce28493c834e442d45c52c68
042 |a dc 
100 1 0 |a Tom Bellmann  |e author 
700 1 0 |a Jana Thamm  |e author 
700 1 0 |a Uwe Beekmann  |e author 
700 1 0 |a Dana Kralisch  |e author 
700 1 0 |a Dagmar Fischer  |e author 
245 0 0 |a In situ Formation of Polymer Microparticles in Bacterial Nanocellulose Using Alternative and Sustainable Solvents to Incorporate Lipophilic Drugs 
260 |b MDPI AG,   |c 2023-02-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics15020559 
500 |a 1999-4923 
520 |a Bacterial nanocellulose has been widely investigated in drug delivery, but the incorporation of lipophilic drugs and controlling release kinetics still remain a challenge. The inclusion of polymer particles to encapsulate drugs could address both problems but is reported sparely. In the present study, a formulation approach based on in situ precipitation of poly(lactic-co-glycolic acid) within bacterial nanocellulose was developed using and comparing the conventional solvent <i>N</i>-methyl-2-pyrrolidone and the alternative solvents poly(ethylene glycol), Cyrene<sup>TM</sup> and ethyl lactate. Using the best-performing solvents <i>N</i>-methyl-2-pyrrolidone and ethyl lactate, their fast diffusion during phase inversion led to the formation of homogenously distributed polymer microparticles with average diameters between 2.0 and 6.6 µm within the cellulose matrix. Despite polymer inclusion, the water absorption value of the material still remained at ~50% of the original value and the material was able to release 32 g/100 cm<sup>2</sup> of the bound water. Mechanical characteristics were not impaired compared to the native material. The process was suitable for encapsulating the highly lipophilic drugs cannabidiol and 3-O-acetyl-11-keto-β-boswellic acid and enabled their sustained release with zero order kinetics over up to 10 days. Conclusively, controlled drug release for highly lipophilic compounds within bacterial nanocellulose could be achieved using sustainable solvents for preparation. 
546 |a EN 
690 |a bacterial nanocellulose 
690 |a microparticles 
690 |a PLGA 
690 |a drug delivery 
690 |a cannabidiol 
690 |a boswellic acids 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 15, Iss 2, p 559 (2023) 
787 0 |n https://www.mdpi.com/1999-4923/15/2/559 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/d94e7b4cce28493c834e442d45c52c68  |z Connect to this object online.